Percutaneous coronary intervention of unprotected left main and bifurcation in octogenarians: Subanalysis from RAIN (veRy thin stents for patients with left mAIn or bifurcatioN in real life)
Federico Conrotto MD
Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy
Search for more papers by this authorFabrizio D'Ascenzo MD
Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy
Search for more papers by this authorCorresponding Author
Francesco Piroli MD
Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy
Correspondence
Francesco Piroli, Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy.
Email: [email protected]
Search for more papers by this authorAlfonso Franzé MD
Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy
Search for more papers by this authorLeonardo de Luca MD
U.O.C. Cardiologia, Ospedale San Giovanni Evangelista, Rome, Italy
Search for more papers by this authorGiorgio Quadri MD
Department of Cardiology, Infermi Hospital, Turin, Italy
Search for more papers by this authorNicola Ryan MD
Department of Cardiology, Hospital Clinico San Carlos, Madrid, Spain
Search for more papers by this authorJavier Escaned MD
Department of Cardiology, Hospital Clinico San Carlos, Madrid, Spain
Search for more papers by this authorMario Bo MD
Division of Geriatrics, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy
Search for more papers by this authorGaetano Maria De Ferrari MD
Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy
Search for more papers by this authorFederico Conrotto MD
Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy
Search for more papers by this authorFabrizio D'Ascenzo MD
Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy
Search for more papers by this authorCorresponding Author
Francesco Piroli MD
Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy
Correspondence
Francesco Piroli, Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy.
Email: [email protected]
Search for more papers by this authorAlfonso Franzé MD
Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy
Search for more papers by this authorLeonardo de Luca MD
U.O.C. Cardiologia, Ospedale San Giovanni Evangelista, Rome, Italy
Search for more papers by this authorGiorgio Quadri MD
Department of Cardiology, Infermi Hospital, Turin, Italy
Search for more papers by this authorNicola Ryan MD
Department of Cardiology, Hospital Clinico San Carlos, Madrid, Spain
Search for more papers by this authorJavier Escaned MD
Department of Cardiology, Hospital Clinico San Carlos, Madrid, Spain
Search for more papers by this authorMario Bo MD
Division of Geriatrics, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy
Search for more papers by this authorGaetano Maria De Ferrari MD
Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy
Search for more papers by this authorAbstract
Objective
Outcomes of complex percutaneous coronary interventions (PCIs) in older patients are still debated.
The aim of the study was to evaluate clinical outcomes of Octogenarian patients treated with ultrathinstents on left main or on coronary bifurcations, compared with younger patients.
Methods
All consecutive patients presenting a critical lesion of an unprotected left main (ULM) or a bifurcation and treated with very thin stents were included in the RAIN (veRy thin stents for patients with left mAIn or bifurcatioN in real life) registry and divided into octogenarians group (OG, 551 patients) and nonoctogenarians (NOGs, 2,453 patients). Major adverse cardiovascular event (MACE), a composite end point of all-cause death, nonfatal myocardial infarction (MI), target lesion revascularization (TLR), and stent thrombosis (ST), was the primary endpoint, while MACE components, cardiovascular (CV) death, and target vessel revascularization (TVR) were the secondary ones.
Results
Indication for PCI was acute coronary syndrome in 64.7% of the OG versus 53.1% of the NOG. Severe calcifications and a diffuse disease were significantly more in OG. After a follow-up of 15.2 ± 10.3 months, MACEs were higher in the OG than in the NOG patients (OG 19.1% vs. NOG 11.2%, p < .001), along with MI (OG 6% vs. NOG 3.4%, p = .002) and all-cause death (OG 14% vs. NOG 4.3%, p < .001). In contrast, no significant difference was detected in CV-death (OG 5.1% vs. NOG 4%, p = .871), TVR/TLR, or ST. At multivariate analysis, age was not an independent predictor of MACE (OR 1.02 CI 95% 0.76–1.38), while it was for all-cause death, along with diabetes, GFR < 60 ml/min, and ULM disease.
Discussion
Midterm outcomes of complex PCI in OG are similar to those of younger patients. However, due to the higher non-CV death rate, accurate patient selection is mandatory.
REFERENCES
- 1Over 27 million people aged 80 and over in the EU. Eurostat Web site. http://ec.europa.eu/eurostat/web/products-eurostat-news/-/EDN-20170930-1. Accessed June 24, 2018.
- 2Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18): 1837-1847.
- 3Grundy SM. Age as a risk factor: you are as old as your arteries. Am J Cardiol. 1999; 83(10): 1455-1457.
- 4Avezum A, Makdisse M, Spencer F, et al. Impact of age on management and outcome of acute coronary syndrome: observations from the global registry of acute coronary events (GRACE). Am Heart J. 2005; 149(1): 67-73.
- 5Rothwell PM, Coull AJ, Silver LE, et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford vascular study). Lancet. 2005; 366(9499): 1773-1783.
- 6Newby LK. Acute coronary syndromes in the elderly. J Cardiovasc Med. 2011; 12(3): 220-222.
10.2459/JCM.0b013e328343e9ce Google Scholar
- 7Gale CP, Cattle BA, Woolston A, et al. Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The myocardial Ischaemia National Audit Project 2003-2010. Eur Heart J. 2012; 33(5): 630-639.
- 8Sanchis J, Bonanad C, Ruiz V, et al. Frailty and other geriatric conditions for risk stratification of older patients with acute coronary syndrome. Am Heart J. 2014; 168(5): 784-791.
- 9Smith LG, Herlitz J, Karlsson T, Berger AK, Luepker RV. International comparison of treatment and long-term outcomes for acute myocardial infarction in the elderly: Minneapolis/St. Paul, MN, USA and Goteborg, Sweden. Eur Heart J. 2013; 34(41): 3191-3197.
- 10Amann U, Kirchberger I, Heier M, et al. Predictors of non-invasive therapy and 28-day-case fatality in elderly compared to younger patients with acute myocardial infarction: an observational study from the MONICA/KORA myocardial infarction registry. BMC Cardiovasc Disord. 2016; 16: 151.
- 11DeGeare VS, Stone GW, Grines L, et al. Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials). Am J Cardiol. 2000; 86(1): 30-34.
- 12Antonsen L, Jensen LO, Terkelsen CJ, et al. Outcomes after primary percutaneous coronary intervention in octogenarians and nonagenarians with ST-segment elevation myocardial infarction: from the Western Denmark heart registry. Catheter Cardiovasc Interv. 2013; 81(6): 912-919.
- 13Batchelor WB, Anstrom KJ, Muhlbaier LH, et al. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. J Am Coll Cardiol. 2000; 36(3): 723-730.
- 14Singh M, Mathew V, Garratt KN, et al. Effect of age on the outcome of angioplasty for acute myocardial infarction among patients treated at the Mayo Clinic. Am J Med. 2000; 108(3): 187-192.
- 15Vandecasteele EH, De Buyzere M, Gevaert S, et al. Reperfusion therapy and mortality in octogenarian STEMI patients: results from the Belgian STEMI registry. Clin Res Cardiol. 2013; 102(11): 837-845.
- 16Somma KA, Bhatt DL, Fonarow GC, et al. Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction. Circ Cardiovasc Qual Outcomes. 2012; 5(5): 654-661.
- 17Reinius P, Mellbin L, Holzmann MJ, Siddiqui AJ. Percutaneous coronary intervention versus conservative treatment for non ST-segment elevation myocardial infarction in patients above 80 years of age. Int J Cardiol. 2018; 267: 57-61.
- 18Tegn N, Abdelnoor M, Aaberge L, et al. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (after eighty study): an open-label randomised controlled trial. Lancet. 2016; 387(10023): 1057-1065.
- 19 TIME Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial. Lancet. 2001; 358(9286): 951-957.
- 20Fox KAA, Clayton TC, Damman P, et al. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J Am Coll Cardiol. 2010; 55(22): 2435-2445.
- 21Ibánez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Rev Espanola Cardiol. 2017; 70(12): 1082.
- 22ClinicalTrials.gov Database. Very thin stents for patients with left main or bifurcation in real life: the RAIN a multicenter study. https://clinicaltrials.gov/ct2/show/NCT03544294. October 21, 2018.
- 23Miura T, Miyashita Y, Motoki H, et al. In-hospital clinical outcomes of elderly patients (≥80 years) undergoing percutaneous coronary intervention. Circ J. 2014; 78(5): 1097-1103.
- 24Nicolini F, Contini GA, Fortuna D, et al. Coronary artery surgery versus percutaneous coronary intervention in octogenarians: long-term results. Ann Thorac Surg. 2015; 99(2): 567-574.
- 25Conrotto F, Scacciatella P, D'Ascenzo F, et al. Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a drug-eluting stent for left main artery registry substudy). Am J Cardiol. 2014; 113(12): 2007-2012.
- 26Anderson HV, Cannon CP, Stone PH, et al. One-year results of the thrombolysis in myocardial infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol. 1995; 26(7): 1643-1650.
- 27Wallentin L, Swahn E. Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study FRagmin and fast revascularisation during instability in coronary artery disease investigators. Lancet. 1999; 354(9180): 701-707.
- 28Lagerqvist B, Husted S, Kontny F, et al. A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study. J Am Coll Cardiol. 2002; 40(11): 1902-1914.
- 29Bach RG, Cannon CP, Weintraub WS, et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med. 2004; 141(3): 186-195.
- 30Dziewierz A, Siudak Z, Rakowski T, Dubiel JS, Dudek D. Age-related differences in treatment strategies and clinical outcomes in unselected cohort of patients with ST-segment elevation myocardial infarction transferred for primary angioplasty. J Thromb Thrombolysis. 2012; 34(2): 214-221.
- 31Bueno H, Betriu A, Heras M, et al. Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies. Eur Heart J. 2011; 32(1): 51-60.
- 32Stone GW, Grines CL, Browne KF, et al. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the primary angioplasty in myocardial infarction (PAMI) trail. J Am Coll Cardiol. 1995; 25(2): 370-377.
- 33Brieger D, Eagle KA, Goodman SG, et al. Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the global registry of acute coronary events. Chest. 2004; 126(2): 461-469.
- 34O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2013; 61(4): 78-140.
- 35Topaz G, Finkelstein A, Flint N, et al. Comparison of 30-day and long-term outcomes and hospital complications among patients aged <75 versus ≥75 years with ST-elevation myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol. 2017; 119(12): 1897-1901.
- 36Lopes RD, Gharacholou SM, Holmes DN, et al. Cumulative incidence of death and rehospitalization among the elderly in the first year after NSTEMI. Am J Med. 2015; 128(6): 582-590.
- 37Ekerstad N, Swahn E, Janzon M, et al. Frailty is independently associated with 1-year mortality for elderly patients with non-ST-segment elevation myocardial infarction. Eur J Prev Cardiol. 2014; 21(10): 1216-1224.
- 38Matsuzawa Y, Konishi M, Akiyama E, et al. Association between gait speed as a measure of frailty and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol. 2013; 61(19): 1964-1972.
- 39Gharacholou SM, Roger VL, Lennon RJ, et al. Comparison of frail patients versus nonfrail patients ≥65 years of age undergoing percutaneous coronary intervention. Am J Cardiol. 2012; 109(11): 1569-1575.
- 40Singh M, Rihal CS, Lennon RJ, Spertus JA, Nair KS, Roger VL. Influence of frailty and health status on outcomes in patients with coronary disease undergoing percutaneous revascularization. Circ Cardiovasc Qual Outcomes. 2011; 4(5): 496-502.
- 41Di Bari M, Balzi D, Fracchia S, et al. Decreased usage and increased effectiveness of percutaneous coronary intervention in complex older patients with acute coronary syndromes. Heart. 2014; 100(19): 1537-1542.
- 42Rowe R, Iqbal J, Murali-Krishnan R, et al. Role of frailty assessment in patients undergoing cardiac interventions. Open Heart. 2014; 1(1):e000033.
- 43Moretti C, Quadri G, D'Ascenzo F, et al. THE STORM (acute coronary syndrome in patients end of life and risk assesment) study. Emerg Med J. 2016; 33(1): 10-16.
- 44Reinecke H, Trey T, Matzkies F, Fobker M, Breithardt G, Schaefer RM. Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions. Kidney Int. 2003; 63(2): 696-701.
- 45Lin M-J, Lee J, Chen C-Y, Huang C-C, Wu H-P. Chronic kidney disease and diabetes associated with long-term outcomes in patients receiving percutaneous coronary intervention. BMC Cardiovasc Disord. 2017; 17: 242.
- 46Hammoud T, Tanguay JF, Bourassa MG. Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol. 2000; 36(2): 355-365.
- 47Tehrani S, Laing C, Yellon DM, Hausenloy DJ. Contrast-induced acute kidney injury following PCI. Eur J Clin Invest. 2013; 43(5): 483-490.
- 48Neumann F-J, Sousa-Uva M, Ahlsson A, et al. ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2018; 40(2019): 87-165.
- 49Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014; 130(25): 2354-2394.
- 50Hamm CW, Bassand J-P, Agewall S, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011; 32(23): 2999-3054.